Apyx Medical Corp. (NASDAQ: APYX) reported Q1 EPS of ($0.22), $0.09 worse than the analyst estimate of ($0.13). Revenue for the quarter came in at $10.2 million versus the consensus estimate of $13.72 million.

GUIDANCE:

Apyx Medical Corp. sees FY2024 revenue of $49.7-52.9 million, versus the consensus of $49.94 million.

For earnings history and earnings-related data on Apyx Medical Corp. (APYX) click here.